Skip to main content
Signal8

THOMSON TODD S

SEC insider (Form 3/4/5 filer). CIK 0001225707. Director & 10% Owner at ACTUATE THERAPEUTICS, INC. (ACTU) and 1 other issuer. 3 reported Form 4/5 transactions since Sep 2024; latest on May 21, 2026. Located in BEVERLY HILLS, CA.

Companies THOMSON TODD S has filed insider reports for

  • ACTUATE THERAPEUTICS, INC. (ACTU): Director, 10% Owner
  • ZOOZ Strategy Ltd. (ZOOZ): Director
THOMSON TODD S profile photo

THOMSON TODD S

CIK: 0001225707

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)1 (33.3%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

ACTUATE THERAPEUTICS, INC. logo
ACTU

ACTUATE THERAPEUTICS, INC.

Director10% Owner
ZOOZ Strategy Ltd. logo
ZOOZ

ZOOZ Strategy Ltd.

Director

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • ACTUATE THERAPEUTICS, INC. logo
    ACTU

    ACTUATE THERAPEUTICS, INC.

    May 21, 2026
    Award

    Stock Options

    Direct
    15K shares-
  • ACTUATE THERAPEUTICS, INC. logo
    ACTU

    ACTUATE THERAPEUTICS, INC.

    Jan 5, 2026
    Sale
    Indirect
    280K shares at avg. $5.80$1.6M
  • ACTUATE THERAPEUTICS, INC. logo
    ACTU

    ACTUATE THERAPEUTICS, INC.

    May 22, 2025
    Award

    Stock Options

    Direct
    15K shares-

1-3 of 3